发明名称 |
Particles containing a growth factor, and uses thereof |
摘要 |
The present invention concerns particles containing at least one covalently cross-linked polysaccharide and at least one growth factor, a method of preparation, and uses thereof. |
申请公布号 |
US9238008(B2) |
申请公布日期 |
2016.01.19 |
申请号 |
US201214002435 |
申请日期 |
2012.03.05 |
申请人 |
Institut National de la Sante et da la Recherche Medicale (INSERM);Centre National de la Recherche Scientifique (CNRS);Universite de Rouen;Universite de Reims Champagne-Ardennes;Centre Hospitalier Universitaire de Rouen |
发明人 |
Brakenhielm Ebba;Banquet Sébastien;Edwards-Levy Florence;Thuillez Christian |
分类号 |
A61K9/50;A61K38/18;A61K47/42;A61K38/01;A61K38/19;A61K38/22;A61K38/27 |
主分类号 |
A61K9/50 |
代理机构 |
Whitham Curtis Christofferson & Cook, PC |
代理人 |
Whitham Curtis Christofferson & Cook, PC |
主权项 |
1. A method of treatment of cardiovascular diseases in a patient in need thereof, comprising administering to said patient a therapeutically effective amount of at least one growth factor,
wherein said at least one growth factor is released from particles containing a network or a membrane and said at least one growth factor, wherein said network or membrane comprises at least one covalently cross-linked polysaccharide and a protein, wherein said protein is co-cross-linked with the at least one covalently cross-linked polysaccharide, wherein said at least one growth factor is adsorbed by electrostatic interactions to the at least one covalently cross-linked polysaccharide, wherein the polysaccharide is selected from the group consisting of acacia gum, alginic acid and derivatives thereof, alginic salts, alginic esters, chondroitin-4-sulfate, chondroitin-6-sulfate, and mixtures thereof, wherein the protein is selected from the group consisting of albumins, said therapeutically effective amount being administered by injection into a tissue of the patient, and wherein the particles provide sustained release of the growth factor over a period of at least 15 days. |
地址 |
Paris FR |